Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men

Annals of the New York Academy of Sciences

Volumn 949, Issue , 2001, Pages 168-174

  Blum, Arnon ^a   Cannoniii, Richard O ^b,c  

^a Poriya Hospital   (Israel)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atherosclerosis; Estrogen; Hemostasis; Inflammation; Lipoproteins; Nitric oxide; Raloxifene; Tamoxifen

Indexed keywords

BENZOTHIOPHENE DERIVATIVE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DROLOXIFENE; ESTROGEN; ESTROGEN RECEPTOR; LIPOPROTEIN; NITRIC OXIDE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0035680412     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb04016.x     Document Type: Conference Paper

References (29)

1. Menopause and the risk of coronary heart disease in women
2. Estrogen replacement and coronary heart disease: A quantitative assessment of the epidemiologic evidence
3. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
4. Raloxifene, tamoxifene, nafoxidine, and estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats
5. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene
6. In search of optimal long-term female hormone replacement: The potential of selective estrogen receptor modulators
7. Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women
8. Raloxifene (LY139481 HCl) prevents bone loss and reduce serum cholesterol without causing uterine hypertrophy in ovariectomized rats
9. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
10. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
11. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol fed rabbits
12. Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys
13. Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism
14. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women
15. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B
16. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
17. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study
18. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
19. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
20. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
21. Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women
22. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
23. 17 Beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease
24. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men
25. Arterial reactivity is enhanced in genetic males taking high dose estrogens
26. Long-term estrogen therapy improves vascular function in male to female transsexuals
27. Induction of calcium-dependent nitric oxide synthases by sex hormones
28. Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males
29. Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men